News for Bristol-Myers Squibb Company (BRM.DE)

Intel plunged 8% after reporting weaker-than-expected guidance, setting a cautious tone for the tech sector. Attention now shifts to upcoming mega-cap tech

LAVAL, QC / ACCESS Newswire / July 24, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, today announced th

Baron Health Care Fund declined for the quarter but outperformed its benchmark, the Russell 3000 Health Care Index. Read more here.

We recently published 8 Stocks That Jim Cramer Recently Talked About. Bristol-Myers Squibb Company (NYSE:BMY) is one of the stocks Jim Cramer recently discussed. Bristol-Myers Squibb Company (NYSE:BMY) is one of the largest and most well-known American pharmaceutical companies. It has long been one of Cramer’s favorite stocks as the CNBC TV host has been […]

Bristol-Myers Squibb Company (NYSE:BMY) is one of the largest and most well-known American pharmaceutical companies.

Bristol-Myers Squibb Company (NYSE:BMY) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. The company has dealt with some hurdles in the past, but it has secured several key new drug approvals in recent years. One of the most notable is Reblozyl, a treatment for anemia in individuals with beta-thalassemia, a […]

The company has dealt with some hurdles in the past, but it has secured several key new drug approvals in recent years.

The US pharmaceutical industry has undergone notable shifts in recent years, influenced by factors such as the COVID-19 pandemic, expanded collaborations across the value chain, and ongoing changes in...

Recently, Zacks.com users have been paying close attention to Bristol Myers (BMY). This makes it worthwhile to examine what the stock has in store.

Originally published by The Robert A. Winn Excellence In Clinical Trials Award Program NORTHAMPTON, MA / ACCESS Newswire / July 14, 2025 / The Robert A. Winn Cl

SOMERSET, N.J., July 14, 2025 (GLOBE NEWSWIRE) -- CompoSecure, Inc. ( CMPO), a leader in metal payment cards, security, and authentication solutions, today an

Bristol-Myers Squibb is set to announce its second-quarter results by the end of July, and analysts expect a notable drop in earnings.

On June 17, the company declared a quarterly dividend of $0.62 per share, which was consistent with its previous dividend.

Bristol-Myers Squibb Company (NYSE:BMY) is included among the 10 Best Passive Income Stocks to Buy Now. On June 17, the company declared a quarterly dividend of $0.62 per share, which was consistent with its previous dividend. Overall, it has raised its payouts for 16 consecutive years and has delivered uninterrupted payouts for 93 years in […]

Bristol-Myers Squibb Company (NYSE:BMY) is one of the 10 Best Cheap Stocks to Buy According to Billionaire Ray Dalio. Bridgewater Associates holds over $142 million worth of shares of BMY, which represents 0.66% of its portfolio. On June 25, 2025, Bristol-Myers Squibb Company (NYSE:BMY) announced a new update regarding its plans for breast cancer treatments. […]

Business Insider's July 30 virtual event features executives talking about procurement innovation strategies. The panel features experts from Bristol-Myers Squibb and Amazon Business.

Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

**media[660849,660850]**